Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: Results of a prospective randomized phase II study

By Esteban Emilio   Fra Joaquin   Fernández Yolanda   Corral Norberto   Vieitez José   Palacio Isabel   Sande José   Fernández José   Muñiz Isabel   Villanueva Noemi   Estrada Enrique   Mareque Beatriz   Uña Esther   Buesa José   Lacave Angel  

Investigational New Drugs, Vol. 24, Iss. 3, 2006-05 ,pp. : 241-248

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine and mitoxantrone in metastatic breast cancer: A phase-I-study

By Schmid Peter   Flath Bernd   Akrivakis Konstantin   Heilmann Volker   Mergenthaler Hans-Günther   Sezer Orhan   Kreienberg Rolf   Possinger Kurt  

Investigational New Drugs, Vol. 23, Iss. 4, 2005-08 ,pp. : 349-356

Springer Publishing Company

Access to resources Recommend Favorite

Vinorelbine + mitomycin for metastatic breast cancer

By  

Inpharma, Vol. 1, Iss. 1304, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Vinorelbine + mitomycin for metastatic breast cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 329, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy)

By Schilling G.   Bruweleit M.   Harbeck N.   Thomssen C.   Becker K.   Hoffmann R.   Villena C.   Schütte M.   Hossfeld D.   Bokemeyer C.   Wit M.  

Investigational New Drugs, Vol. 27, Iss. 2, 2009-04 ,pp. : 166-172

Springer Publishing Company

Access to resources Recommend Favorite